世界のゴーシェ病＆ポンペ病酵素補充療法（ERT）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4244 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法（ERT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ポンペ病）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の市場動向 ・企業の競争状況、市場シェア ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の種類別市場規模と予測2016-2027（ゴーシェ病、ポンペ病） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の用途別市場規模と予測2016-2027（乳児、子供、大人） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の北米市場規模2016-2027（アメリカ、カナダ） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ゴーシェ病＆ポンペ病酵素補充療法（ERT）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer Inc.、Alexion Pharmaceuticals Inc.、BioMarin Pharmaceutical Inc.、Ultragenyx Pharmaceutical Inc.、Janssen Pharmaceuticals Inc.、Sigma-Tau Pharmaceuticals Inc.、AbbVie Inc.、Sanofi SA、Shire PLC、Merck KGaA、Tadeka Pharmaceuticals） ・結論

A type of resistance measuring device which measure the grounding resistance of various devices and the conductor resistance of low resistance.

Market Analysis and Insights: Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market
The global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market.

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Scope and Market Size
Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gaucher Disease
Pompe Disease

Segment by Application
Baby
Child
Adult

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc.
Alexion Pharmaceuticals Inc.
BioMarin Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Janssen Pharmaceuticals Inc.
Sigma-Tau Pharmaceuticals Inc.
AbbVie Inc.
Sanofi SA
Shire PLC
Merck KGaA
Tadeka Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gaucher Disease
1.2.3 Pompe Disease
1.3 Market by Application
1.3.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Baby
1.3.3 Child
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Perspective (2016-2027)
2.2 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Growth Trends by Regions
2.2.1 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Historic Market Share by Regions (2016-2021)
2.2.3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Regions (2022-2027)
2.3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Industry Dynamic
2.3.1 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Trends
2.3.2 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Drivers
2.3.3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Challenges
2.3.4 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players by Revenue
3.1.1 Global Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players by Revenue (2016-2021)
3.1.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Players (2016-2021)
3.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue
3.4 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Concentration Ratio
3.4.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in 2020
3.5 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Key Players Head office and Area Served
3.6 Key Players Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Solution and Service
3.7 Date of Enter into Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Breakdown Data by Type
4.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Historic Market Size by Type (2016-2021)
4.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Type (2022-2027)

5 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Breakdown Data by Application
5.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Historic Market Size by Application (2016-2021)
5.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (2016-2027)
6.2 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type
6.2.1 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021)
6.2.2 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027)
6.2.3 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2027)
6.3 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application
6.3.1 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021)
6.3.2 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027)
6.3.3 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2027)
6.4 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country
6.4.1 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021)
6.4.2 North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (2016-2027)
7.2 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type
7.2.1 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021)
7.2.2 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027)
7.2.3 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2027)
7.3 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application
7.3.1 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021)
7.3.2 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027)
7.3.3 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2027)
7.4 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country
7.4.1 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021)
7.4.2 Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (2016-2027)
8.2 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type
8.2.1 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application
8.3.1 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Region
8.4.1 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (2016-2027)
9.2 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type
9.2.1 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021)
9.2.2 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027)
9.2.3 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2027)
9.3 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application
9.3.1 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021)
9.3.2 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027)
9.3.3 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2027)
9.4 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country
9.4.1 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021)
9.4.2 Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (2016-2027)
10.2 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type
10.2.1 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application
10.3.1 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country
10.4.1 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.1.4 Pfizer Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.1.5 Pfizer Inc. Recent Development
11.2 Alexion Pharmaceuticals Inc.
11.2.1 Alexion Pharmaceuticals Inc. Company Details
11.2.2 Alexion Pharmaceuticals Inc. Business Overview
11.2.3 Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.2.4 Alexion Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.2.5 Alexion Pharmaceuticals Inc. Recent Development
11.3 BioMarin Pharmaceutical Inc.
11.3.1 BioMarin Pharmaceutical Inc. Company Details
11.3.2 BioMarin Pharmaceutical Inc. Business Overview
11.3.3 BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.3.4 BioMarin Pharmaceutical Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.3.5 BioMarin Pharmaceutical Inc. Recent Development
11.4 Ultragenyx Pharmaceutical Inc.
11.4.1 Ultragenyx Pharmaceutical Inc. Company Details
11.4.2 Ultragenyx Pharmaceutical Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.4.4 Ultragenyx Pharmaceutical Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.4.5 Ultragenyx Pharmaceutical Inc. Recent Development
11.5 Janssen Pharmaceuticals Inc.
11.5.1 Janssen Pharmaceuticals Inc. Company Details
11.5.2 Janssen Pharmaceuticals Inc. Business Overview
11.5.3 Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.5.4 Janssen Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.5.5 Janssen Pharmaceuticals Inc. Recent Development
11.6 Sigma-Tau Pharmaceuticals Inc.
11.6.1 Sigma-Tau Pharmaceuticals Inc. Company Details
11.6.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
11.6.3 Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.6.4 Sigma-Tau Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.6.5 Sigma-Tau Pharmaceuticals Inc. Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.7.4 AbbVie Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.7.5 AbbVie Inc. Recent Development
11.8 Sanofi SA
11.8.1 Sanofi SA Company Details
11.8.2 Sanofi SA Business Overview
11.8.3 Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.8.4 Sanofi SA Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.8.5 Sanofi SA Recent Development
11.9 Shire PLC
11.9.1 Shire PLC Company Details
11.9.2 Shire PLC Business Overview
11.9.3 Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.9.4 Shire PLC Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.9.5 Shire PLC Recent Development
11.10 Merck KGaA
11.10.1 Merck KGaA Company Details
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.10.4 Merck KGaA Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.10.5 Merck KGaA Recent Development
11.11 Tadeka Pharmaceuticals
11.11.1 Tadeka Pharmaceuticals Company Details
11.11.2 Tadeka Pharmaceuticals Business Overview
11.11.3 Tadeka Pharmaceuticals Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Introduction
11.11.4 Tadeka Pharmaceuticals Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
11.11.5 Tadeka Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gaucher Disease
Table 3. Key Players of Pompe Disease
Table 4. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Regions (2016-2021)
Table 8. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Regions (2022-2027)
Table 10. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Trends
Table 11. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Drivers
Table 12. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Challenges
Table 13. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Restraints
Table 14. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Players (2016-2021)
Table 16. Global Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) as of 2020)
Table 17. Ranking of Global Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Solution and Service
Table 21. Date of Enter into Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Type (2016-2021)
Table 25. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Application (2016-2021)
Table 29. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Inc. Company Details
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 64. Pfizer Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 65. Pfizer Inc. Recent Development
Table 66. Alexion Pharmaceuticals Inc. Company Details
Table 67. Alexion Pharmaceuticals Inc. Business Overview
Table 68. Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 69. Alexion Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 70. Alexion Pharmaceuticals Inc. Recent Development
Table 71. BioMarin Pharmaceutical Inc. Company Details
Table 72. BioMarin Pharmaceutical Inc. Business Overview
Table 73. BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 74. BioMarin Pharmaceutical Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 75. BioMarin Pharmaceutical Inc. Recent Development
Table 76. Ultragenyx Pharmaceutical Inc. Company Details
Table 77. Ultragenyx Pharmaceutical Inc. Business Overview
Table 78. Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 79. Ultragenyx Pharmaceutical Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 80. Ultragenyx Pharmaceutical Inc. Recent Development
Table 81. Janssen Pharmaceuticals Inc. Company Details
Table 82. Janssen Pharmaceuticals Inc. Business Overview
Table 83. Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 84. Janssen Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 85. Janssen Pharmaceuticals Inc. Recent Development
Table 86. Sigma-Tau Pharmaceuticals Inc. Company Details
Table 87. Sigma-Tau Pharmaceuticals Inc. Business Overview
Table 88. Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 89. Sigma-Tau Pharmaceuticals Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 90. Sigma-Tau Pharmaceuticals Inc. Recent Development
Table 91. AbbVie Inc. Company Details
Table 92. AbbVie Inc. Business Overview
Table 93. AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 94. AbbVie Inc. Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 95. AbbVie Inc. Recent Development
Table 96. Sanofi SA Company Details
Table 97. Sanofi SA Business Overview
Table 98. Sanofi SA Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 99. Sanofi SA Recent Development
Table 100. Shire PLC Company Details
Table 101. Shire PLC Business Overview
Table 102. Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 103. Shire PLC Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 104. Shire PLC Recent Development
Table 105. Merck KGaA Company Details
Table 106. Merck KGaA Business Overview
Table 107. Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 108. Merck KGaA Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 109. Merck KGaA Recent Development
Table 110. Tadeka Pharmaceuticals Company Details
Table 111. Tadeka Pharmaceuticals Business Overview
Table 112. Tadeka Pharmaceuticals Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product
Table 113. Tadeka Pharmaceuticals Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021) & (US$ Million)
Table 114. Tadeka Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type: 2020 VS 2027
Figure 2. Gaucher Disease Features
Figure 3. Pompe Disease Features
Figure 4. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application: 2020 VS 2027
Figure 5. Baby Case Studies
Figure 6. Child Case Studies
Figure 7. Adult Case Studies
Figure 8. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Report Years Considered
Figure 9. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Regions: 2020 VS 2027
Figure 12. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Regions (2022-2027)
Figure 13. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Players in 2020
Figure 14. Global Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in 2020
Figure 16. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Type (2016-2021)
Figure 17. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share by Type (2022-2027)
Figure 18. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type (2016-2027)
Figure 20. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application (2016-2027)
Figure 21. North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Country (2016-2027)
Figure 22. United States Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type (2016-2027)
Figure 26. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application (2016-2027)
Figure 27. Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Country (2016-2027)
Figure 28. Germany Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Region (2016-2027)
Figure 38. China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type (2016-2027)
Figure 46. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application (2016-2027)
Figure 47. Latin America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Country (2016-2027)
Figure 48. Mexico Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Share by Country (2016-2027)
Figure 54. Turkey Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 58. Alexion Pharmaceuticals Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 59. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 60. Ultragenyx Pharmaceutical Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 61. Janssen Pharmaceuticals Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 62. Sigma-Tau Pharmaceuticals Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 63. AbbVie Inc. Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 64. Sanofi SA Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 65. Shire PLC Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 66. Merck KGaA Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 67. Tadeka Pharmaceuticals Revenue Growth Rate in Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---